biotech merger
Longevity Biotech Takes Root on Nasdaq With $180M SPAC Deal
Longevity Biotech; Nasdaq; SPAC deal; public listing; FutureTech II Acquisition Corp.; clinical development; biotech merger; age-related diseases
BioNTech Acquires CureVac to Advance mRNA Cancer Therapies and End Patent Disputes
BioNTech; CureVac; mRNA; acquisition; COVID-19 vaccine; cancer immunotherapy; merger; patent dispute; biotech merger
HOOKIPA Pharma Terminates Acquisition Talks with Poolbeg Pharma
biotech merger, acquisition termination, HOOKIPA Pharma, Poolbeg Pharma, immunotherapeutics, rare disease